Inna Martin Eitan
RMI PARTNERS
Coda Therapeutics
New Zealand
Biography
Inna Martin Eitan has over 16 years of business development, managerial and entrepreneurial experience in the pharmaceutical and medical device industries. Prior to joining RMI Partners, she founded and managed a consultancy firm that provided business development and consulting services to companies in the pharma, medtech and biotech fields. Inna has also served as a strategic business development and financial consultant to several leading venture funds and companies traded at NASDAQ in USA and Canada and TASE in Israel. She provided consulting on business development and investment raising issues for such biomedical technology companies as Hadassit Bio Holdings, BetaO2, Godji, Maayan Ventures, Peregrine, Molecular Cytomics, Nextar (Aminolab Pharma)and world-known division of Stem Cell Research at the Technion Research & Development Foundation in Israel. In addition to participating in the development of RMI Partners, Inna also is a member of the Board of Directors of ReVision Optics Inc. аnd Ocon Medical Ltd.
Research Interest
Research iNterest oN Pharmaceuticals
